Scientific updates

Recent developments in research

• 
  Connecting the Dots: EGFR-mutated lung cancerFebruary 27, 2026
• 
  LCRF + AstraZeneca launch SCLC grantFebruary 24, 2026
• 
  Science Update | Winter 2026February 6, 2026
• 
  A record year for supporting researchJanuary 29, 2026
• 
  Lung cancer in 2025January 28, 2026
• 
  Subcutaneous amivantamabJanuary 27, 2026

---

Science Made Simple

• 
  Lung cancer in 2025January 28, 2026
• 
  Subcutaneous amivantamabJanuary 27, 2026
• 
  Sevabertinib for HER2+ lung cancerDecember 1, 2025
• 
  Zongertinib for HER2+ lung cancerAugust 28, 2025
• 
  Sunvozertinib for EGFR Exon 20+ NSCLCAugust 25, 2025
• 
  NeoADAURA trial shows promising resultsJuly 28, 2025
• 
  ADC for EGFR+ lung cancer gets accelerated approvalJuly 7, 2025
• 
  New treatment for ROS1+ non-small cell lung cancerJune 25, 2025
• 
  Accelerated approval for c-MET directed ADCJune 12, 2025

---

Recent FDA approvals